Brief: Pasithea Therapeutics Acquires Allomek Therapeutics

Pasithea Therapeutics

12/10/2022 13:10

Oct 12 (Reuters) - Pasithea Therapeutics Corp  KTTA.O :
    * PASITHEA THERAPEUTICS ACQUIRES ALLOMEK THERAPEUTICS
    * PASITHEA THERAPEUTICS CORP - PLANS TO FILE IND APPLICATION
WITH
THE FDA TO ENTER THE CLINIC IN 2H 2023
    * PASITHEA THERAPEUTICS CORP - PLANS TO INITIATE A PHASE 1
CLINICAL TRIAL IN U.S. FOR NEUROFIBROMATOSIS TYPE 1 (NF1)
    * PASITHEA THERAPEUTICS - ACQUIRED EQUITY INTERESTS IN
ALLOMEK IN
FOR $1.05 MILLION UPFRONT CASH PAYMENT, 2.7 MILLION SHARES OF
RESTRICTED COMMON STOCK PLUS 5-YEAR WARRANTS

Source text for Eikon:  ID:nGNX38Y6kv 
Further company coverage:  KTTA.O 
 ((Reuters.Briefs@thomsonreuters.com;))